Tanihara Fuminori, Hirata Maki, Namula Zhao, Do Lanh Thi Kim, Yoshimura Naoaki, Lin Qingyi, Takebayashi Koki, Sakuma Tetsushi, Yamamoto Takashi, Otoi Takeshige
Faculty of Bioscience and Bioindustry, Tokushima University, Tokushima, Japan.
Bio-Innovation Research Center, Tokushima University, Tokushima, Japan.
Front Cell Dev Biol. 2023 Jan 13;11:884340. doi: 10.3389/fcell.2023.884340. eCollection 2023.
Just one amino acid at the carboxy-terminus of the B chain distinguishes human insulin from porcine insulin. By introducing a precise point mutation into the porcine () gene, we were able to generate genetically modified pigs that secreted human insulin; these pigs may be suitable donors for islet xenotransplantation. The electroporation of the CRISPR/Cas9 gene-editing system into zygotes is frequently used to establish genetically modified rodents, as it requires less time and no micromanipulation. However, electroporation has not been used to generate point-mutated pigs yet. In the present study, we introduced a point mutation into porcine zygotes electroporation using the CRISPR/Cas9 system to generate point-mutated pigs as suitable islet donors. We first optimized the efficiency of introducing point mutations by evaluating the effect of Scr7 and the homology arm length of ssODN on improving homology-directed repair-mediated gene modification. Subsequently, we prepared electroporated zygotes under optimized conditions and transferred them to recipient gilts. Two recipients became pregnant and delivered five piglets. Three of the five piglets carried only the biallelic frame-shift mutation in the gene, whereas the other two successfully carried the desired point mutation. One of the two pigs mated with a WT boar, and this desired point mutation was successfully inherited in the next F1 generation. In conclusion, we successfully established genetically engineered pigs with the desired point mutation electroporation-mediated introduction of the CRISPR/Cas9 system into zygotes, thereby avoiding the time-consuming and complicated micromanipulation method.
B链羧基末端的一个氨基酸差异使得人胰岛素与猪胰岛素区分开来。通过在猪的()基因中引入精确的点突变,我们能够培育出分泌人胰岛素的基因编辑猪;这些猪可能是胰岛异种移植的合适供体。将CRISPR/Cas9基因编辑系统电穿孔导入受精卵常用于培育基因编辑啮齿动物,因为它所需时间较少且无需显微操作。然而,电穿孔尚未用于培育点突变猪。在本研究中,我们使用CRISPR/Cas9系统通过电穿孔将点突变引入猪受精卵,以培育出作为合适胰岛供体的点突变猪。我们首先通过评估Scr7和单链寡脱氧核苷酸(ssODN)的同源臂长度对改善同源定向修复介导的基因修饰的影响,优化了引入点突变的效率。随后,我们在优化条件下制备了电穿孔受精卵,并将其移植到受体后备母猪体内。两只受体母猪怀孕并产下了五只仔猪。五只仔猪中有三只仅在基因中携带双等位移码突变,而另外两只成功携带了所需的点突变。两只猪中的一只与野生型公猪交配,所需的点突变在下一代F1代中成功遗传。总之,我们通过将CRISPR/Cas9系统电穿孔介导引入受精卵,成功培育出具有所需点突变的基因工程猪,从而避免了耗时且复杂的显微操作方法。